Omalizumab treatment downregulates dendritic cell FcεRI expression
Calman Prussin(National Institutes of Health), Thomas B. Casale(University of South Florida), Barbara A. Foster(Roswell Park Comprehensive Cancer Center), D.T. Griffith(Creighton University), K.M. Boesel(Creighton University), Henry C. Lin(Oregon Health & Science University)
Cited by 346
Related Papers
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations
|American Journal of Respiratory and Critical Care Medicine|2009|1.9k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision
|Journal of Allergy and Clinical Immunology|2010|1.8k
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
|Journal of Allergy and Clinical Immunology|2011|1.2k
Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
|New England Journal of Medicine|2013|1.1k